Company / Revenue
Axogen, Inc. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$225.2M
FY2025
5-year range
$106.7M / $225.2M
FY2021-FY2025
Trend
+20.2%
vs FY2024
Sector context
#141 of 156
Health Care
What the data says
Among 156 Health Care companies, Axogen, Inc. is in the bottom 10% for revenue. Revenue has increased for 5 consecutive years, from $84M in FY2020 to $225M in FY2025.
Based on SEC 10-K filings.
$225M in FY2025 with a 5-year CAGR of +21.8%.
Improved from $159M to $225M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +26.1%
- 5-Year CAGR
- +21.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 156This company $225.2M Sector average $19.0B
▼
-98.8% below sector average
Key checks
Key Insights
- Axogen, Inc.'s revenue has grown for 5 consecutive years.
- 5-year CAGR of +21.8%, indicating consistent growth.
- In FY2025, revenue increased 20.2% year-over-year.
- Ranks #141 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- Negative profit margin: -5.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $225.2M | +20.2% |
| FY2024 | $187.3M | +17.8% |
| FY2023 | $159.0M | +41.6% |
| FY2022 | $112.3M | +5.2% |
| FY2021 | $106.7M | +27.1% |
| FY2020 | $83.9M | -21.3% |
| FY2019 | $106.7M | +159.6% |
| FY2018 | $41.1M | -32.0% |
| FY2017 | $60.4M | +121.1% |
| FY2016 | $27.3M | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026